Medical Marijuana, Inc. Overview
Company Headquarters: Oregon, US
Founded: 2005
Workforce: 85
Company Working: Medical Marijuana, Inc. is the world’s first legal supplier of cannabidiol products. Medical Marijuana Inc. is a holding company that operates through its various subsidiaries such as Kannaway, LLC, HempMeds Brasil, Canchew Biotechnologies LLC, HempMeds PX, LLC, The Hemp Network, Canipa Holdings, aNew Chocolate, LLC, MJNA Investment Holdings, LLC, and Dixie Elixirs, LLC. The company’s focus area includes the creation of the international CBD pipeline, the manufacture of legal cannabis consumer products and cannabis drugs, the development of new markets for medical cannabis, and the provision of support services for the cannabis industry. It is the first company to deliver prescription CBD products for various health applications such as Alzheimer’s disease, Epilepsy, Parkinson’s disease, chronic pain, and migraine. Additionally, in 2017, HempMeds, the international subsidiary of Medical Marijuana, Inc., became the first company to have a cannabis-based product, RSHO-X, subsidized by a government in Mexico.
Strategy
Medical Marijuana, Inc. is focused on acquiring new businesses and products which will strategically complement its business model. Moreover, the company has a strong CBD product pipeline for ensuring growth in the company’s share in the near future. It is also focused on expanding its product line through R&D spending. Furthermore, it is expanding its reach in Latin America through its subsidiary, and its subsidiaries are also collaborating to study the therapeutic effects of cannabis products.



